Seems like great timing for BCLI. In phase 3 and received $16 million grant last year which indicated there are positive results from its phase 2 trial treatments, enough to pony up $16 million. Also very bullish report this month, I just added to my position at $3.15.

http://scr.zacks.com/News/Press-Releases/Pres...fault.aspx